Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (73 total)
-
Autor: FDA
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2023-05-12
Descripción: The Emergency Use Authorization (EUA) authority allows FDA to help strengthen the nation’s public health protections against chemical, biological, radiological, and nuclear (CBRN) threats including infectious diseases, by facilitating the… -
Autor: FDA
Tema: Research
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022-07-20
Descripción: Current Federal law requires that a drug be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship the investigational drug to clinical investigators… -
Autor: CITI Program
Tema: Laboratory
Tipo de elemento: Hipervínculo
Fecha de actualización: 2022
Descripción: The Collaborative Institutional Training Initiative (CITI Program) is dedicated to serving the training needs of colleges and universities, healthcare institutions, technology and research organizations, and governmental agencies, as they foster… -
Autor: Editor Bruce Hawkins
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2019
Descripción: The purpose of these guidelines is to describe a standardized approach for the management of investigational drug products by the clinical research pharmacy, pharmaceutical industry, and cooperative and research network groups. -
Autor: Jocelyn J Herstein, Paul D Biddinger, Shawn G Gibbs, Angela L Hewlett, Aurora B Le, Michelle M Schwedhelm, John J Lowe
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2022-02-22
Descripción: In response to the 2014-2016 West Africa Ebola virus disease (EVD) epidemic, the Centers for Disease Control and Prevention (CDC) designated 56 US hospitals as Ebola treatment centers (ETCs) with high-level isolation capabilities. We aimed to… -
Autor: Abigail E Lowe, Colleen Kraft, Mark G Kortepeter, Keith F Hansen, Kristine Sanger, Ann Johnson, Jonathan D Grein, Julie Martin, Rebecca Rousselle, Jennifer A Garland, Jessica Spotts, John J Lowe, Lauren M Sauer, Christopher J Kratochvil, Bruce G…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2022-05-31
Descripción: Research is foundational for evidence-based management of patients. Clinical research, however, takes time to plan, conduct, and disseminate—a luxury that is rarely available during a public health emergency. The University of Nebraska Medical Center… -
Autor: Lauren M Sauer, Vikramjit Mukherjee
Tema: Emergency Management
Tipo de elemento: Publicación
Fecha de actualización: 2022-05-31
Descripción: The inextricable link between infectious disease preparedness and healthcare continues on full display as we move through the third year of the COVID-19 pandemic. At the forefront of this link are the organizations, hospitals, and health systems that… -
Autor: ACTT- Study Group
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2022-05-23
Descripción: Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone plus remdesivir in preventing progression to… -
Autor: Kimon C Zachary, Erica S Shenoy
Tema: Infection Control
Tipo de elemento: Publicación
Fecha de actualización: 2022-06-09
Descripción: Transmission risk of monkeypox in healthcare settings outside endemic regions has not been well defined. A rapid review of the literature, including cases outside monkeypox-endemic regions from 2000 to 2022 identified a single reported case of…